Fundies. English
ADARx Pharmaceuticals, Inc.
EDGAR1 filing records in this dataset, filed from 2026-09-04 to 2026-09-04. Explore the available filing history and original sources.
Registration statement
This company has filed to register securities with the SEC and has not yet filed an annual or quarterly report. Its financial statements are in the filing itself rather than structured data, so reported figures appear here once periodic reports are filed.
- Registration statement (S-1) · filed 2026-09-04 Open filing documents
Offering terms · S-1 · 2026-09-04
- Security
- Common Stock, $0.0001 par value per share
- Maximum offering price
- USD 100,000,000
- Registration fee
- USD 13,810 · 0.0138%
The maximum offering price is the amount the registration fee is computed on, not what the company expects to raise. The offering size and price range are in the prospectus.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
1 filings · 0 latest values · 0 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001802369, 1802369, edgar:1802369
Also known as ADARx Pharmaceuticals, Inc.